Gene: SLC30A1
Official Full Name: solute carrier family 30 member 1provided by HGNC
Gene Summary: Predicted to enable calcium channel inhibitor activity and zinc:proton antiporter activity. Involved in defense response to bacterium; intracellular zinc ion homeostasis; and zinc ion import into organelle. Located in several cellular components, including Golgi apparatus; basolateral plasma membrane; and nuclear membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01845 | SLC30A1 Knockout cell line (HeLa) | Human | SLC30A1 | 1:3~1:6 | Negative | Online Inquiry |
KO01846 | SLC30A1 Knockout cell line (HCT 116) | Human | SLC30A1 | 1:2~1:4 | Negative | Online Inquiry |
KO01847 | SLC30A1 Knockout cell line (HEK293) | Human | SLC30A1 | 1:3~1:6 | Negative | Online Inquiry |
KO01848 | SLC30A1 Knockout cell line (A549) | Human | SLC30A1 | 1:3~1:4 | Negative | Online Inquiry |
SLC30A1 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically disrupt the SLC30A1 gene, which encodes for the Zinc Transporter 1 (ZnT1). This transporter plays a crucial role in the regulation of zinc homeostasis within cells, mediating the efflux of zinc ions to maintain optimal intracellular zinc concentrations essential for various biological processes. By creating knockout models, researchers can investigate the functional implications of silencing this gene, allowing for an in-depth understanding of zinc's role in cellular signaling, metabolic pathways, and disease mechanisms.
The primary function of these cell lines is to facilitate the study of zinc-related biological processes, such as cellular proliferation, apoptosis, and oxidative stress. The knockout of the SLC30A1 gene presents a unique opportunity to explore how the absence of ZnT1 affects cellular responses under pathological conditions and influences disease states like cancer, neurodegeneration, and metabolic disorders. Furthermore, these cell lines can serve as critical tools for drug development, aiding in the screening of therapeutic compounds that target zinc transport mechanisms.
In scientific research and clinical applications, SLC30A1 Gene Knockout Cell Lines offer distinct advantages over traditional models, such as primary cells and simpler in vitro systems. Their genetic uniformity allows for reproducible experiments, while the targeted genetic alteration enables the isolation of specific cellular functions related to zinc regulation. Additionally, the availability of these specialized models addresses the growing demands for advanced tools that can yield insights into zinc biology and its implications in human health.
For researchers and clinicians alike, the utility of SLC30A1 Knockout Cell Lines lies in their capacity to provide insightful data that can lead to novel therapeutic strategies and enhanced understanding of cellular behavior in zinc homeostasis. They represent a valuable addition to the repertoire of molecular tools available for basic and translational research.
Our company specializes in delivering high-quality biological products and genetically modified cell lines to empower researchers in their pursuit of scientific advancement. With an unwavering commitment to excellence and innovation, we are dedicated to providing tools that support groundbreaking discoveries in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.